NEW YORK (GenomeWeb) – Eurofins Scientific announced today that its subsidiaries Eurofins BioDiagnostics and Eurofins STA Laboratories have merged into a single company in the seed, plant, and agricultural diagnostics market.

According to Eurofins Scientific, the merger joins Eurofins BioDiagnostics' analytical and genetic service capabilities with Eurofins STA's seed and plant health expertise to create a complete ag-bio analytical testing company. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.